Isatuximab in Combination With Lenalidomide-Dexamethasone Compared to Lenalidomide-Dexamethasone in Elderly Patients (Aged ≥70 Years) With Newly Diagnosed Myeloma: a Randomized Phase II Study (SGZ-2019-12650)
Latest Information Update: 23 Sep 2024
At a glance
- Drugs Isatuximab (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms AGMT-MM-4; SGZ-2019-12650
- 14 Feb 2022 New source identified and integrated (European Clinical Trials Database: EudraCT2020-004972-17).
- 29 Oct 2021 Status changed from not yet recruiting to recruiting.
- 20 Jul 2021 Planned initiation date changed from 1 Jul 2021 to 1 Oct 2021.